MARTIN MACKAY Insider Trading $ALXN ALEXION PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for MARTIN MACKAY.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of MARTIN MACKAY. MARTIN MACKAY is Senior Vice President in PFIZER INC ($PFE) and EVP & Global Head of R&D in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in CHARLES RIVER LABORATORIES INTERNATIONAL INC ($CRL).
MARTIN MACKAY in ALEXION PHARMACEUTICALS, INC.
Trading Symbol: ALXNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of MARTIN MACKAY: EVP & Global Head of R&D
Holdings: 38,883 shares
Current Value: $4,966,137
Latest Transaction: Mar 01 2017
$ALXN Market Capitalization: $28.30B
$ALXN Previous Close: $127.72
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of MARTIN MACKAY in ALEXION PHARMACEUTICALS, INC.
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, CRL, PFE
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Option Exercise | A | 131.25 | 12,800 | 1,680,000 | 12,800 | |
Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 132.50 | 370 | 49,025 | 50,688 | 51.1 K to 50.7 K (-0.72 %) |
Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Grant | A | 0.00 | 12,800 | 0 | 51,058 | 38.3 K to 51.1 K (+33.46 %) |
Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 131.70 | 625 | 82,313 | 38,258 | 38.9 K to 38.3 K (-1.61 %) |
Mar 01 2017 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 131.20 | 860 | 112,832 | 38,883 | 39.7 K to 38.9 K (-2.16 %) |
Feb 10 2017 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 126.84 | 217 | 27,524 | 39,743 | 40 K to 39.7 K (-0.54 %) |
Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 126.88 | 18 | 2,284 | 39,960 | 40 K to 40 K (-0.05 %) |
Feb 08 2017 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 125.69 | 2,710 | 340,620 | 39,978 | 42.7 K to 40 K (-6.35 %) |
May 18 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 140.43 | 18 | 2,528 | 42,688 | 42.7 K to 42.7 K (-0.04 %) |
May 18 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 139.19 | 4,079 | 567,756 | 42,706 | 46.8 K to 42.7 K (-8.72 %) |
Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Option Exercise | A | 140.16 | 31,000 | 4,344,960 | 31,000 | |
Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 138.91 | 1,000 | 138,910 | 46,785 | 47.8 K to 46.8 K (-2.09 %) |
Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Grant | A | 0.00 | 7,000 | 0 | 47,785 | 40.8 K to 47.8 K (+17.16 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 138.02 | 1,908 | 263,342 | 40,785 | 42.7 K to 40.8 K (-4.47 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 140.32 | 58 | 8,139 | 42,693 | 42.8 K to 42.7 K (-0.14 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 140.47 | 1,043 | 146,510 | 42,751 | 43.8 K to 42.8 K (-2.38 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 141.19 | 400 | 56,476 | 43,794 | 44.2 K to 43.8 K (-0.91 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 142.11 | 100 | 14,211 | 44,194 | 44.3 K to 44.2 K (-0.23 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 143.53 | 100 | 14,353 | 44,294 | 44.4 K to 44.3 K (-0.23 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 144.40 | 362 | 52,273 | 44,394 | 44.8 K to 44.4 K (-0.81 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Buy | S | 145.54 | 100 | 14,554 | 44,756 | 44.7 K to 44.8 K (+0.22 %) |
Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Grant | A | 0.00 | 11,763 | 0 | 44,656 | 32.9 K to 44.7 K (+35.76 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Option Exercise | M | 176.80 | 15,375 | 2,718,300 | 33,825 | |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Option Exercise | M | 104.86 | 28,125 | 2,949,188 | 37,500 | |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 195.19 | 8,882 | 1,733,678 | 32,893 | 41.8 K to 32.9 K (-21.26 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 196.48 | 17,518 | 3,441,937 | 41,775 | 59.3 K to 41.8 K (-29.54 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 197.24 | 17,100 | 3,372,804 | 59,293 | 76.4 K to 59.3 K (-22.38 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Buy | M | 176.80 | 15,375 | 2,718,300 | 76,393 | 61 K to 76.4 K (+25.20 %) |
Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Buy | M | 104.86 | 28,125 | 2,949,188 | 61,018 | 32.9 K to 61 K (+85.50 %) |
May 22 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 160.33 | 4,056 | 650,298 | 32,893 | 36.9 K to 32.9 K (-10.98 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Option Exercise | A | 180.37 | 24,400 | 4,401,028 | 24,400 | |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Sell | S | 180.34 | 370 | 66,726 | 36,949 | 37.3 K to 36.9 K (-0.99 %) |
Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | MACKAY MARTIN | EVP & Global Head o ... | Grant | A | 0.00 | 5,100 | 0 | 37,319 | 32.2 K to 37.3 K (+15.83 %) |
Page: 1